EcoDrugPlus

Thromboxane A2 Receptor

Ensembl ID : ENSMMDG00005006533
Gene Symbol: TBXA2R
1 Cross references
192 Possible Orthologues:

Thromboxane-A Synthase-Like

Ensembl ID : ENSMMDG00005009627
Gene Symbol: LOC115361058
3 Cross references
217 Possible Orthologues:

Thromboxane-A Synthase-Like

Ensembl ID : ENSMMDG00005009697
Gene Symbol: LOC115361010
3 Cross references
217 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSMMDG00005002741
Gene Symbol: TYMP
3 Cross references
172 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSMMDG00005007223
Gene Symbol: TYMS
3 Cross references
224 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSMMDG00005008240
Gene Symbol: THRB
3 Cross references
389 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSMMDG00005022735
Gene Symbol: TRHR
3 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor-Like

Ensembl ID : ENSMMDG00005006308
Gene Symbol: LOC115367999
3 Cross references
193 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSMMDG00005020536
Gene Symbol: TLR2
1 Cross references
210 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010597
Gene Symbol: TAAR1
1 Cross references
620 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010596
Gene Symbol: TAAR1
1 Cross references
620 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMMDG00005010590
Gene Symbol: TAAR1
3 Cross references
620 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).